CLINICAL_TRIALS
trial_result
· 2019-09-23
Clinical Trial Update: A Study of Nasal Glucagon in Participants With Type 1 Diabetes Mellitus [Phase 1]
Summary
Phase 1 trial evaluating nasal glucagon in participants with type 1 diabetes completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Hypoglycemia, Diabetes Mellitus, Type 1 | Phase 1 | Status: COMPLETED | Results posted: 2019-09-23